Chronic granulomatous disease presenting with eosinophilic inflammation

Pediatric Infectious Disease Journal

Volumn 24, Issue 11, 2005, Pages 1020-1021

  Jaggi, Preeti ^a   Freeman, Alexandra F ^a   Katz, Ben Z ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Chronic granulomatous disease; Eosinophilia; Inflammation

Indexed keywords

ACHROMOBACTER XYLOSOXIDANS; ARTICLE; ASPERGILLOSIS; CASE REPORT; CHRONIC GRANULOMATOUS DISEASE; CLINICAL FEATURE; CYSTITIS; DIAGNOSTIC PROCEDURE; EOSINOPHIL; GASTROENTERITIS; HUMAN; HUMAN TISSUE; INFLAMMATION; LYMPHADENITIS; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; THORAX DISEASE; THORAX WALL; URINARY TRACT DISEASE; VESICOURETERAL REFLUX;

EID: 28044463997     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000183775.69035.33     Document Type: Article

References (17)

1. Goldblatt D, Thrasher AJ. Chronic granulomatous disease. Clin Exp Immunol. 2000;122:1-9.
2. Winkelstein JA, Marino MC, Johnston RB Jr, et al. Chronic granulomatous disease: report on a national registry of 368 patients. Medicine (Baltimore). 2000;79:155-169.
3. O'Gorman MR, Corrochano V. Rapid whole-blood flow cytometry assay for diagnosis of chronic granulomatous disease. Clin Diagn Lab Immunol. 1995;2:227-232.
4. Kuribayashi F, Kumatori A, Suzuki S, Nakamura M, Matsumoto T, Tsuji Y. Human peripheral eosinophils have a specific mechanism to express gp91-phox, the large subunit of cytochrome b558. Biochem Biophys Res Commun. 1995;209:146-152.
5. Weening RS, De Boer M, Kuijpers TW, Neefjes VM, Hack WW, Roos D. Point mutations in the promoter region of the CYBB gene leading to mild chronic granulomatous disease. Clin Exp Immunol. 2000;122:410-417.
6. Moy JN, Gleich GJ, Thomas LL. Noncytotoxic activation of neutrophils by eosinophil granule major basic protein: effect on superoxide anion generation and lysosomal enzyme release. J Immunol. 1990;145:2626-2632.
7. Gallin JI, Alling DW, Malech HL, et al. Itraconazole to prevent fungal infections in chronic granulomatous disease. N Engl J Med. 2003;348:2416-2422.
8. Bauer SB, Kogan SJ. Vesical manifestations of chronic granulomatous disease in children: its relation to eosinophilic cystitis. Urology. 1991; 37:463-466.
9. Ament ME, Ochs HD. Gastrointestinal manifestations of chronic granulomatous disease. N Engl J Med. 1973;288:382-387.
10. Schappi MG, Smith VV, Goldblatt D, Lindley KJ, Milla PJ. Colitis in chronic granulomatous disease. Arch Dis Child. 2001;84:147-151.
11. Schappi MG, Klein NJ, Lindley KJ, et al. The nature of colitis in chronic granulomatous disease. J Pediatr Gastroenterol Nutr. 2003;36:623-631.
12. Walther MM, Malech H, Berman A, et al. The urological manifestations of chronic granulomatous disease. J Urol. 1992;147:1314-1318.
13. Aliabadi H, Gonzalez R, Quie PG. Urinary tract disorders in patients with chronic granulomatous disease. N Engl J Med. 1989;321:706-708.
14. Chin TW, Stiehm ER, Falloon J, Gallin JI. Corticosteroids in treatment of obstructive lesions of chronic granulomatous disease. J Pediatr. 1987;111:349-352.
15. Duggan JM, Goldstein SJ, Chenoweth CE, Kauffman CA, Bradley SF. Achromobacter xylosoxidans bacteremia: report of four cases and review of the literature. Clin Infect Dis. 1996;23:569-576.
16. Hearn YR, Gander RM. Achromobacter xylosoxidans: an unusual neonatal pathogen. Am J Clin Pathol. 1991;96:211-214.
17. Weitkamp JH, Tang YW, Haas DW, Midha NK, Crowe JE Jr. Recurrent Achromobacter xylosoxidans bacteremia associated with persistent lymph node infection in a patient with hyper-immunoglobulin M syndrome. Clin Infect Dis. 2000;31:1183-1187.